Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAP2K5

RBC: MEK5 · Substrate: ERK5 (K84R) ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Nintedanib98.60.61
Ponatinib96.70.53
Dasatinib96.20.70
Vemurafenib94.40.60
Dabrafenib88.70.63
Canertinib73.20.67
Erlotinib70.90.69
Avapritinib54.90.64
Rabusertib53.90.69
Gefitinib48.50.65
Osimertinib46.80.73
Regorafenib44.80.72
Dacomitinib36.20.66
Ripretinib36.20.67
Crizotinib34.10.58

Known variants

No variants catalogued.
Open in new tab